• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.04% Nasdaq Up2.19%

    Seattle Genetics, Inc. (SGEN)

    27.29 Down 1.75(6.04%) 10:32AM EST - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.4
    Mean Recommendation (last week):2.4

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:48.27
    Median Target:51.00
    High Target:65.00
    Low Target:30.00
    No. of Brokers:13

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 4, 2016BarclaysInitiated Overweight
    Jan 21, 2016Credit SuisseInitiated Outperform
    Nov 18, 2015GoldmanInitiated Sell
    Oct 30, 2015Piper JaffrayUpgradeUnderweightNeutral
    Jul 9, 2014UBSUpgradeNeutralBuy
    Feb 13, 2013NeedhamDowngradeBuyHold
    Nov 8, 2012Cantor FitzgeraldDowngradeHoldSell
    Sep 7, 2012OppenheimerDowngradeOutperformPerform
    Aug 21, 2012Cantor FitzgeraldInitiated Buy
    Nov 11, 2011NeedhamInitiated Buy

    More Upgrades & Downgrades for SGEN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2222

    Data provided by Thomson/First Call

    Currency in USD.